on July 10, 2026
The epicenter of our metabolic world
Unlike other organs, the liver represents the true fulcrum of our internal balance. It is an extraordinarily valuable anatomical district but, at the same time, exposed to continuous biochemical loads, precisely because it is at the center of systemic metabolism, where all substances ingested through any route converge. At the same time, the liver operates as a vital center that synthesizes and distributes active molecules throughout the entire organism, making its homeostasis essential for overall health. Its functions are multiple, complex, and in constant dynamic balance with the other systems. Hormonal turmoil, a circulatory problem, a dietary imbalance, a substrate deficiency, or an infection can cause complex functional alterations which, if prolonged over time, evolve into stable organ damage with inevitable systemic repercussions.
This organ is particularly susceptible to the action of drugs, since it plays a primary role in biotransformation processes. These biochemical pathways do not always follow detox finalistic criteria, since sometimes the resulting metabolite has higher toxicity than the original molecule. Drugs tend to concentrate in the liver tissue, which can see its metabolic makeup altered even by dietary factors. Most hepatotoxic reactions are not related to dosage, but rather to hypersensitivity phenomena developed over time, even at therapeutic doses. From this emerges the importance of a physiological and preventive intervention aimed at preserving the organ's functionality before it becomes diseased. The rational use of medicinal plants offers the opportunity to support the parenchyma, reducing in specific contexts the need to resort to potentially hepatotoxic molecules such as non-steroidal anti-inflammatory drugs, antipyretics, and antibiotics. On the contrary, there is a real risk of precipitating the function of a suffering organ, but still in the compensation phase, due to concomitant diseases, reckless dietary behaviors, or the ideological refusal of innovative therapies.
The silent transition of hepatic steatosis
The term steatosis defines the common picture of fatty liver, characterized by an accumulation of triglycerides within the hepatocytes. If in the past this condition was minimized from a clinical point of view, modern scientific medicine considers it with extreme attention, identifying it as a precise transition zone towards chronic and potentially irreversible evolutionary phases. When a patient reports the presence of mild steatosis, as if it were an innocuous overweight of the organ, the need arises to exercise maximum medical vigilance. The subject could be in a completely reversible initial phase, or in an intermediate stage complicated by an active inflammatory picture, with or without a tendency towards fibrosis and cirrhosis. The generic term steatosis is today referred primarily to the anatomopathological picture, preferring in the clinical field the term steatotic liver disease to emphasize the nature of a damage that is often silent, chronic, and progressive. This specific condition represents the ideal ground for a targeted health and herbal intervention.
Steatotic liver disease, although manifesting in the liver, constitutes the focal point of a general disorder involving lifestyle, diet, and the dysfunctions of other systems. The first and essential factor to analyze is the consumption of ethanol, which imposes the distinction between alcoholic and non-alcoholic forms. Alcoholic steatosis represents the onset stage of alcoholic liver disease, which can progress towards acute or chronic steatohepatitis, cirrhosis, and carcinoma. The liver's susceptibility to ethanol shows a marked individual variability related to the duration of the habit and the concomitance of other toxins, although scientific research identifies twenty-five grams per day of ethanol, equivalent to about two glasses of wine, as the critical threshold for the risk of developing cirrhosis. In the face of alcoholic steatosis, the total removal of alcohol constitutes the first therapeutic imperative. The picture is made insidious by the absence of specific symptoms, an element that pushes the patient to minimize the situation even in the face of an initial rise in transaminases, a direct indicator of damage and necrosis affecting the noble cells of the liver.
Non-alcoholic steatotic liver disease, historically known as NAFLD and today framed within metabolic alterations, is not related to alcohol but is configured as the hepatic manifestation of metabolic syndrome, supported by insulin resistance as the main pathophysiological driver. This form affects from fifteen percent of the general population to sixty percent of subjects with metabolic risk factors, first among all of them diabetes mellitus, showing a direct correlation with overweight and obesity even in childhood. It is divided into forms with or without an inflammatory and fibrotic component. Identifying the progression of damage is the exclusive task of the doctor, but early intervention on initial metabolic alterations allows for the implementation of real prevention.
Physiological intervention strategies and the biochemistry of fibers
In the presence of steatosis not complicated by active hepatitis, lifestyle modification acts as a primary therapeutic pillar. Among the modifiable factors, smoking cessation reduces pro-inflammatory stimuli, while habitual coffee consumption has demonstrated in epidemiological settings a protective role. From a dietary point of view, the introduction of plant fibers reduces lipid absorption and modulates postprandial glycemia. The use of extracts rich in mucilage, such as Mallow roots, or phytocomplexes rich in polyphenols and anthocyanins with marked antioxidant activity is useful. The use of remedies in the form of herbal tea offers indisputable physiological advantages, including the absence of synthetic chemical solvents, the extraction of soluble polysaccharides capable of positively modulating the intestinal microbiota, the wide dilution of active principles, and the mechanical washing action operated by the complexed water on the digestive tract.
Plants of the herbal tradition such as Artichoke, Rosemary, Agrimony, and Fumitory, if properly mixed, favor choleuresis and the removal of lipids from the liver tissue, while reducing dyspeptic symptoms, postprandial drowsiness, and abdominal bloating. When the organ must face the load of hepatotoxic pharmacological therapies, such as the prolonged use of paracetamol, anti-inflammatory drugs, or chemotherapeutic agents, Milk Thistle and its preferred phytocomplex, silymarin, offer solid protection. Silymarin acts by stabilizing the cellular and lysosomal membranes of hepatocytes, exerts an action as a radical scavenger, inhibits lipid peroxidation, and blocks the synthesis of pro-inflammatory leukotrienes, exhibiting antifibrotic effects. Furthermore, it accelerates protein biosynthesis and stimulates glucuroconjugation, showing a known competitive antagonism towards lethal toxins such as amanitin.
To counteract hyperglycemia and insulin resistance at the intestinal level, Glucomannan, a polysaccharide extracted from the root of Amorphophallus konjac, proves to be an effective complementary tool if taken after meals, since it reduces the impact of the glucose peak and the consequent compensatory hyperinsulinemia. In the presence of established alterations such as diabetes or dyslipidemias, the therapeutic approach must be global, integrating plants such as Licorice, Turmeric, Schisandra, and Phyllanthus, useful in mitigating the inflammatory component that precedes fibrosis.
True prevention rests on the total restriction of alcohol, sweets, simple sugars, and beverages added with fructose, associated with body weight reduction and regular physical activity performed three to five times a week. The diet must favor plant proteins and polyunsaturated fatty acids compared to animal-derived saturated fats, strictly excluding refined flours. White 00 flour, deprived of the germ and bran for industrial preservation purposes, loses much of its biological value and acts as a pro-inflammatory and pro-diabetic stimulus. The whole grain, on the other hand, preserves the vital embryo, preserving a wealth of polyunsaturated oils, B group vitamins, iron, and calcium in percentages clearly higher than the refined product. Insoluble fiber stimulates peristalsis, reduces fermentation phenomena, enriches the microbiome, and lowers the overall glycemic index of the diet.
The role of biological drainage and detoxification cycles
Drainage constitutes a therapeutic method aimed at facilitating the elimination of endogenous and exogenous toxins, deriving from metabolism, drugs, heavy metals, additives, and pesticides, through the natural excretors such as the liver, kidneys, intestine, and skin. This moderate stimulation increases diuresis, choleuresis, and intestinal transit, acting on the constitutional ground of the subject. When the elimination organs slow down, the accumulation of catabolites makes the organism fragile, laying the foundations for the development of pathologies. Ground drainage restores the global balance and should be performed two or three times a year for continuous twenty-one-day cycles.
Based on clinical needs, the doctor can set up a drainage in three precise phases. Pre-therapeutic drainage prepares the subject for the main pharmacological or surgical therapy and lasts for a maximum of two weeks, being excluded in acute cases where targeted intervention is a priority. Intra-therapeutic drainage is inserted during the basic pharmacological treatment to limit its side effects and enhance the organ response. Post-therapeutic drainage, finally, lasts for two or three weeks at the end of therapies to clean the extracellular matrix. Clinical indications include non-impacted gallbladder stones, moderate cholecystitis, and conjugated hyperbilirubinemia pictures from cholelithiasis, always under strict specialist control. Since reduced bile flow compromises the absorption of fat-soluble vitamins A, D, E and favors toxic stasis, drainage finds a logical application also in dermatology for rosacea acne, in non-spastic constipation, in migraine, in dysbiosis, and in autoimmune disorders associated with intestinal congestion. To fortify the gallbladder, nature offers the support of Dandelion, Boldo, Horseradish, Mint, together with a Mediterranean diet rich in cruciferous vegetables, spices, and cold-pressed vegetable oils.
Clinical evidence and tolerability profiles
The clinical efficacy of complex phytotherapeutic treatments has been the subject of rigorous experimental evaluations. A clinical study conducted from 2014 to June 2017 on patients aged between 18 and 70 years with a confirmed diagnosis of NAFLD evaluated the efficacy of the multi-component preparation called Naturocare 15, administered at a dosage of four capsules in the morning for a duration of three months. The primary objectives of the study were the variation of plasma levels of alanine aminotransferase (ALT) and the changes in tissue stiffness measured via FibroScan. At the end of the observational period, the thirty subjects included showed a statistically significant improvement in all anthropometric parameters, liver function biomarkers, and elastographic findings.
A second clinical study lasting twelve weeks examined fifty participants subjected to lifestyle changes in association with four capsules a day of the Naturocare 15-28 complex and one milliliter of natural vitamin D carried in oil. The collected data highlighted a clear reduction in fasting blood sugar, insulinemia, and the HOMA-IR index, reflecting an increase in peripheral insulin sensitivity measured via the QUICKI index. Parallelly, there was a clear improvement in the lipid profile and a quantitative reduction in the percentage of hepatic steatosis. A third study conducted on thirty patients confirmed that the use of four capsules a day of the same complex improves organ parameters and platelet functionality, demonstrating an effective protective action even in subjects exposed for professional reasons to halogenated hydrocarbons.
In contexts of alcohol-induced hepatitis, an intensive protocol based on the administration of four capsules of Naturocare 15 in the morning, four capsules of Naturocare 15-23 at lunch, and four capsules of Naturocare 15-28 at dinner for a duration of six months induced a marked reduction in blood bilirubin, type III collagen propeptide (fibrogenesis marker), and liver enzymes, simultaneously increasing the activity of the antioxidant enzyme glutathione peroxidase. These data were confirmed by the improvements found through molecular imaging and, in a clinical case prolonged up to thirteen months, by positive histopathological changes. The overall program, which involved one hundred and sixty-three patients, demonstrated concrete benefits even in the treatment of diabetes secondary to alcoholic cirrhosis. From a hemodynamic and secretory point of view, the administration in twenty male subjects generated an increase in the duodenal bile flow equal to one hundred and twenty-seven percent after thirty minutes, reaching the peak of one hundred and fifty-one percent after one hour, with an effect prolonged beyond the overall three hours. A further trial on sixty subjects suffering from non-alcoholic steatosis confirmed that two months of standard therapy optimizes the levels of transaminases, total cholesterol, and triglycerides.
From a safety point of view, phytochemical investigations and toxicological data indicate that such protocols present an excellent tolerability profile, with documented clinical uses beyond forty consecutive months without manifestations of organ toxicity. The observed side effects are rare, mild in magnitude, and limited to transient gastrointestinal disturbances or moderate laxative effects. The only real contraindication is represented by proven hypersensitivity to plants belonging to the Asteraceae family. From a pharmacological interaction point of view, it is noted that concomitant intake could reduce the bioavailability of antiprotozoal agents such as metronidazole and increase the clearance of estrogens through the inhibition of the beta-glucuronidase enzyme. The biological risk connected to oral intake remains minimal, while in the absence of definitive data in the literature about safety in pregnancy and during breastfeeding, the use in these specific states must be carefully evaluated by the attending physician.
Bibliographic references
· European Association for the Study of the Liver (EASL) (2018). Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Journal of Hepatology. Study of the European guidelines for the staging and clinical management of steatotic liver disease.
· Silybum marianum Clinical Overview (2022). Pharmacological properties of silymarin: membrane stabilization, antioxidant scavenging and anti-fibrotic mechanisms in hepatic tissue. Phytomedicine. Analysis of the biochemical mechanisms of silymarin in cellular protection and antagonism towards amanitin.
· Glucomannan Metabolic Trial (2023). Efficacy of Amorphophallus konjac polysaccharides on postprandial glycemic spikes and insulin resistance modulation. Diabetes Care. Clinical study on the effects of soluble fibers in the management of metabolic syndrome related to steatosis.
· Naturocare Clinical Study Series (2014-2017). Efficacy of Naturocare 15 and 15-28 complexes on liver stiffness, ALT reduction and lipid profile in NAFLD patients: a multi-center randomized controlled trial. International Journal of Hepatology. Collection of clinical data relating to the efficacy of the phytocomplex on anthropometric parameters and liver elastography.
